NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Yes, nGBM, rGBM and probably also some key categories of patients with certain biomarkers.

The one thing LC points out is yes, even when a doctor can say well over a 100% increase in survival for 5 year survivors they are typically trained to not overstate and tend to understate statistics like that… especially as this is not yet approved. Further, the company is letting the state talk and not actively crafting that language as it should be stated once this is approved. I hope and expect that they will get right on it, but honestly, there is not a single marketer among them, which is a pretty obvious tip off, I think, that they probably won’t be doing the marketing.